Issue Date | Title | Involved Person(s) |
2-Dec-2023 | Wirksamkeitsforschung heute : das Beispiel Depressionsbehandlungen | Hengartner, Michael Pascal |
28-Oct-2023 | Computerspielsucht und Depressivität | Hengartner, Michael Pascal |
Oct-2023 | Neue Horizonte der Migränebehandlung : Patientenorientierte Versorgung – Kogniphobie – Chatbot-Coaching | Kamm, Katharina; Klan, Timo; Ulrich, Sandra |
Sep-2023 | Re: "A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder" by Strawn et al. : concerning harm-benefit ratio in a recent trial about Escitalopram for generalized anxiety disorder | Plöderl, Martin; Horowitz, Mark A.; Hengartner, Michael P. |
16-Jun-2023 | The serotonin hypothesis of depression : both long discarded and still supported? | Moncrieff, Joanna; Cooper, Ruth E.; Stockmann, Tom; Amendola, Simone; Hengartner, Michael P., et al |
23-Mar-2023 | Modelle, Diagnostik und Behandlung der Depression in der Hausarztmedizin | Hengartner, Michael P. |
9-Feb-2023 | No clear evidence of reduced brain serotonin release capacity in patients with depression | Hengartner, Michael P.; Plöderl, Martin |
2023 | Commentary on Karhulahti et al. (2022): exploring gaming disorder from the harmful dysfunction analysis perspective | Amendola, Simone |